Clinical Trials Browser

Phase 1 × EGFR-Mutant Lung Cancer × Erlotinib Hydrochloride × Clear all

NCT01967095 2018-11-13

Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer

Phase 1 Completed

EGFR-Mutant Lung Cancer